TG Therapeutics, Inc.
ロング

$TGTX Stock Set For Breakout Amidst Symmetrical Triangle Pattern

111
TG Therapeutics, Inc. (NASDAQ: TGTX) a biopharmaceutical company, that focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally is set for a breakout amidst a bullish symmetrical triangle pattern.

Analyst Forecast
According to 6 analysts, the average rating for TGTX stock is "Strong Buy." The 12-month stock price forecast is $40.67, which is an increase of 35.16% from the latest price.

Important Dates
The next confirmed earnings date is Monday, March 3, 2025, before market open.

On How the bullish symmetrical plays out is largely incumbent on the earnings report slated for today Monday March 3, 2025 before the bell.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。